baricitinib - living meta-analysis of clinical studies

table network network 2

demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study

	COVID 19 all comers	COVID-19 mild to moderate	COVID-19 severe or critically

	COVID 19 hospitalized	COVID 19 all comers	COVID-19 mild to moderate	COVID-19 severe or critically
baricitinib	COV-BARRIER ACTT-2 ...	RECOVERY	Cantini Rodriguez-Garcia	Tziolos COV-BARRIER ...

1 studies excluded by filtering options 2

6415

Cantini, 2020

2

31

0

excluded

not a RCT

risk of bias not avaialble